ABBV-932 Clinical Trials
3 recruitingDrug
Phase 22Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 2
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD)
AbbVie315 enrolled52 locationsNCT06846320
Recruiting
Phase 1
A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants
Healthy Volunteer
AbbVie8 enrolled1 locationNCT06953934
Recruiting
Phase 2
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
Bipolar I or II Disorder
AbbVie200 enrolled49 locationsNCT07220460